Status:
COMPLETED
A Drug Interaction Study of Montelukast and Levocetirizine
Lead Sponsor:
Hanmi Pharmaceutical Company Limited
Conditions:
Healthy
Eligibility:
MALE
20-55 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to evaluate the drug-drug interaction between montelukast sodium and levocetirizine dihydrochloride in healthy male volunteers.
Eligibility Criteria
Inclusion
- Healthy male
- Age between 20 and 55
- Signed informed consent
Exclusion
- Has a history of hypersensitivity to IP ingredients
- Hypotension or hypertension
- Has a history of acute infection within 14days of screening
Key Trial Info
Start Date :
November 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2012
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT01491503
Start Date
November 1 2011
End Date
January 1 2012
Last Update
April 5 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Samsung medical center
Seoul, South Korea